Shkreli is convicted of fraud. Can pharma finally slam the door on him?
Martin Shrkeli, convicted of fraud on Friday, has been vilified as a price gouger by politicians, the public, and his fellow biopharma execs. What's next?
Is this the end of the line for the “pharma bro” with the perpetual smirk?
Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.
“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”
The big question now: Can the pharma industry finally slam the door on Shkreli, after complaining for nearly two years that his price-hiking antics tainted the reputation of the entire field?
Read more: The Shkreli saga: What’s changed? What hasn’t? And what’s next?
“Shkreli was a
